Position in MRNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$50,759,844
+$12,720,042 QoQ
Shares Held
724,830
-3.2% QoQ
Ownership
0.182%
of shares outstanding
% of Portfolio
0.75%
of 13F equity value
Holder Rank
#46
of 772 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026LETKO, BROSSEAU & ASSOCIATES INC holds $55,170,971 across 18 Biotechnology names. MRNA ranks #1 (92.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
This page
|
724,830 | $50,759,844 | |
| 2 | PVLA |
Palvella Therapeutics, Inc.
|
3,500 | $534,870 | |
| 3 | ELVN |
Enliven Therapeutics, Inc.
|
9,600 | $487,200 | |
| 4 | MGTX |
MeiraGTx Holdings plc
|
32,000 | $432,320 | |
| 5 | GHRS |
GH Research PLC
|
15,425 | $414,624 | |
| 6 | BCAX |
Bicara Therapeutics Inc.
|
11,175 | $331,785 | |
| 7 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,475 | $321,107 | |
| 8 | SPRY |
ARS Pharmaceuticals, Inc.
|
40,050 | $320,800 |
All Filings in MRNA
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $50,759,844 | 724,830 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $38,039,802 | 748,815 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $21,422,715 | 726,440 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $23,592,863 | 913,390 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $25,332,862 | 918,190 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $25,413,648 | 896,425 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $38,392,685 | 923,345 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,159,820 | 511,145 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $37,453,750 | 315,400 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $34,104,528 | 320,050 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $31,767,313 | 319,430 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||